Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease
A Martinez, DI Perez, C Gil - Current topics in medicinal …, 2013 - ingentaconnect.com
Glycogen synthase kinase 3 (GSK-3) inhibitors have aroused a great interest for medicinal
chemists and pharmaceutical companies in the last years. In fact, some candidates have …
chemists and pharmaceutical companies in the last years. In fact, some candidates have …
Cholinesterase inhibition activity and molecular docking study of eugenol derivatives
The study was conducted to explore the anticholinesterase inhibition property of eugenol
derived molecules. Ten eugenol derivatives were synthesized and evaluated for the …
derived molecules. Ten eugenol derivatives were synthesized and evaluated for the …
Impact of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer's disease: a systematic review
C Sheng, W Peng, Z Chen, Y Cao, W Gong… - … and Alternative Medicine, 2016 - Springer
Abstract Background The efficacy of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside
(TSG) treatment on cognitive decline in individuals with Alzheimer's disease (AD) has not …
(TSG) treatment on cognitive decline in individuals with Alzheimer's disease (AD) has not …
Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories
R Fan, Y Zheng, R Zhou, NM Beeraka… - Frontiers in …, 2023 - frontiersin.org
Objective To evaluate the current status of trial registration on the Chinese Clinical Trial
Registry (ChiCTR). Design In this descriptive study, a multi-dimensional grouping analysis …
Registry (ChiCTR). Design In this descriptive study, a multi-dimensional grouping analysis …
Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays
In the current work, we developed a computational pipeline method for predicting the
binding affinities of studied compounds at the specific target sites. Since many approved …
binding affinities of studied compounds at the specific target sites. Since many approved …
Discovery of a novel pyrido [1, 2-a] thiazolo [5, 4-d] pyrimidinone derivatives with excellent potency against acetylcholinesterase
Y Zeng, Z Chen, Z Yang, F Yuan, L Nie, C Niu - Molecular Diversity, 2024 - Springer
As mimetic compounds of the natural alkaloid mackinazolinone, forty pyrido [1, 2-a] thiazolo
[5, 4-d] pyrimidinone were designed and synthesized from a bioisosterism approach. The …
[5, 4-d] pyrimidinone were designed and synthesized from a bioisosterism approach. The …
[HTML][HTML] Effect of organic solvent composition on dissociation constants of some reversible acetylcholinesterase inhibitors
YD Daldal, EÇ Demiralay, SA Ozkan - Journal of the Brazilian …, 2016 - SciELO Brasil
Reversible acetylcholinesterase inhibitors are an important group of drug compounds that
are used medicinally to treat Alzheimer's disease. In this study, dissociation constant values …
are used medicinally to treat Alzheimer's disease. In this study, dissociation constant values …
Assessing individual-level change in dementia research: a review of methodologies
Background Whether in the context of monitoring disease progression or in assessing the
effects of interventions, a major challenge in dementia research is determining when an …
effects of interventions, a major challenge in dementia research is determining when an …
Biochemical changes evidenced in Alzheimer's disease: a mini-review
L Scotti… - Letters in Drug …, 2014 - ingentaconnect.com
Alzheimer's disease is a brain disease that slowly destroys memory and thinking skills, and
eventually, the ability to carry out the simplest tasks. It begins slowly and gets worse over …
eventually, the ability to carry out the simplest tasks. It begins slowly and gets worse over …